Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOTICStandard

VOSOL HC

ACETIC ACID, GLACIAL; HYDROCORTISONE

Standard Dose
2%;1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview VOSOL HC is listed in Drugs@FDA under application 012770 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ACETIC ACID, GLACIAL; HYDROCORTISONE Form and strength SOLUTION/DROPS;OTIC - 2%;1% Sponsor SAPTALIS PHARMS Submission history Latest submission status date: 2024-12-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview VOSOL HC is listed in Drugs@FDA under application 012770 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ACETIC ACID, GLACIAL; HYDROCORTISONE Form and strength SOLUTION/DROPS;OTIC - 2%;1% Sponsor SAPTALIS PHARMS Submission history Latest submission status date: 2024-12-03 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.